cervical adenocarcinoma
Showing 1 - 25 of 40
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Recurrent Cervical Carcinoma Trial in United States (Laboratory
Active, not recruiting
- Cervical Adenocarcinoma
- +5 more
- Laboratory Biomarker Analysis
- Nivolumab
-
Birmingham, Alabama
- +336 more
Jan 28, 2023
Primary Cervical Cancer Screening by Self-sampling HPV Test
Recruiting
- Human Papillomavirus Infection
- +16 more
-
Beijing, Beijing, China
- +5 more
Jan 12, 2023
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,
Recruiting
- Cervical Adenocarcinoma
- +47 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +3 more
Dec 5, 2022
MRI and PET Imaging in Predicting Treatment Response in Stage
Active, not recruiting
- Cervical Adenocarcinoma
- +12 more
- Computed Tomography
- +5 more
-
Miami, Florida
- +5 more
Oct 4, 2022
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen
Recruiting
- Acinar Cell Carcinoma
- +93 more
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +998 more
Aug 23, 2022
Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma, Advanced Vaginal Squamous Cell Carcinoma Trial in
Recruiting
- Advanced Vaginal Adenocarcinoma
- +20 more
- Brachytherapy
- +6 more
-
Birmingham, Alabama
- +383 more
Aug 18, 2022
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Recruiting
- Cervical Adenocarcinoma
- +11 more
- Media Intervention
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Withdrawn
- Cervical Adenocarcinoma
- +6 more
- Carboplatin
- +4 more
-
Cape Town, South Africa
- +2 more
Jun 14, 2022
Clinical Evaluation of Detection of High Risk HPV in Urine
Recruiting
- Human Papillomavirus Infection
- +17 more
-
Beijing, Beijing, China
- +2 more
Jan 21, 2022
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +6 more
- Atezolizumab
- +2 more
-
Los Angeles, California
- +21 more
Apr 20, 2021
Cervical Adenocarcinoma, Cervical Adenocarcinoma In Situ, Cervical Intraepithelial Neoplasia Trial in Houston (Biospecimen
Recruiting
- Cervical Adenocarcinoma
- +54 more
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Houston, Texas
- +1 more
Nov 30, 2020
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +3 more
- Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +23 more
Aug 21, 2020
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +8 more
- Cisplatin
- +4 more
-
Los Angeles, California
- +15 more
Sep 1, 2020
Cervical Adenocarcinoma, Stage IB Cervical Cancer, Stage II Cervical Cancer Trial in France (External Beam Radiation Therapy,
Completed
- Cervical Adenocarcinoma
- +3 more
- External Beam Radiation Therapy
- +2 more
-
Besancon, France
- +8 more
Mar 6, 2020
Cervical Carcinoma, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma Trial run by the NCI (Ixempra (Ixabepilone
Terminated
- Cervical Carcinoma
- +3 more
- Ixempra (Ixabepilone (BMS-247550) )
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 13, 2019
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma Trial in United States (biological,
Completed
- Cervical Adenocarcinoma
- +7 more
- Filgrastim
- +4 more
-
Orange, California
- +77 more
Aug 6, 2019
Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma Trial in Canada, United States
Terminated
- Cervical Adenocarcinoma
- +7 more
-
Birmingham, Alabama
- +281 more
Jul 19, 2019
Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma Trial in Worldwide (radiation,
Completed
- Cervical Adenocarcinoma
- +13 more
- fludeoxyglucose F 18
- +6 more
-
Los Angeles, California
- +32 more
Jul 19, 2019
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +4 more
- Cisplatin
- +3 more
-
Los Angeles, California
- +24 more
Jul 17, 2019
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +4 more
- Brivanib Alaninate
- Laboratory Biomarker Analysis
-
Phoenix, Arizona
- +42 more
Mar 8, 2019
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Unknown status
- Cervical Adenocarcinoma
- +8 more
- Carboplatin
- +4 more
-
Orange, California
- +13 more
Mar 8, 2019
Effects of Immunotherapy, Metastatic/Recurrent Cervical Cancer, Cervical Adenocarcinoma Trial in United States (ADXS11-001)
Completed
- Effects of Immunotherapy
- +8 more
- ADXS11-001
-
Miami, Florida
- +3 more
Mar 4, 2019
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma Trial in United States (Paclitaxel
Completed
- Cervical Adenocarcinoma
- +4 more
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation
- Laboratory Biomarker Analysis
-
Aurora, Colorado
- +25 more
Dec 17, 2018
HPV Integration and Tumorigenesis of Uterine Cervical
Unknown status
- Cervical Adenocarcinoma
- +7 more
- A multi-omics analysis
-
Beijing, Beijing, ChinaLei Li
Nov 13, 2018
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma Trial in Philadelphia (Cisplatin,
Completed
- Cervical Adenocarcinoma
- +4 more
- Cisplatin
- +5 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Sep 18, 2018